Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Abstract 3937: An intracellular variant of zona pellucida glycoprotein 3 is expressed in cancer

Iman J. Schultz, Yvette Zimmerman, Cathy B. Moelans, Marcin Chrusciel, Jan Krijgh, Paul J. van Diest, Ilpo T. Huhtaniemi, Herjan J. Coelingh Bennink

Cancer Res (2023) 83 (7_Supplement): 3937.

https://doi.org/10.1158/1538-7445.AM2023-3937

Published: 04 April 2023

View article titled, Abstract 3937: An intracellular variant of zona pellucida glycoprotein 3 is expressed in cancer

Journal Articles

Abstract P3-12-06: Prognosis of pregnancy-associated breast cancer: Inferior outcome in patients diagnosed during second and third gestational trimesters and lactation

Britt BM Suelmann, Carsten FJ Bakhuis, Carmen van Dooijeweert, Janneke Verloop, Ronald P Zweemer, Sabine C Linn, Elsken van der Wall, Paul J van Diest

Cancer Res (2022) 82 (4_Supplement): P3-12-06.

https://doi.org/10.1158/1538-7445.SABCS21-P3-12-06

Published: 15 February 2022

View article titled, Abstract P3-12-06: Prognosis of pregnancy-associated breast cancer: Inferior outcome in patients diagnosed during second and third gestational trimesters and lactation

Journal Articles

Abstract LB246: E-cadherin loss drives Id2-dependent dampening of cell cycle progression and predicts increased susceptibility to CDK4/6 inhibition in lobular breast cancer

Cancer Res (2021) 81 (13_Supplement): LB246.

https://doi.org/10.1158/1538-7445.AM2021-LB246

Published: 01 July 2021

View article titled, Abstract LB246: E-cadherin loss drives Id2-dependent dampening of cell cycle progression and predicts increased susceptibility to CDK4/6 inhibition in lobular breast cancer

Journal Articles

Abstract OT1-03-02: Combining MRI and liquid biopsies for prediction of response to neoadjuvant chemotherapy in early stage breast cancer: The LIMA study

Liselore Maria Janssen, Britt Berendine Maria Suelmann, Markus Hendrik Adriaan Janse, Sjoerd Geert Elias, Paul J van Diest, Wouter Bernard Veldhuis, Elsken van der Wall, Kenneth George Antonius Gilhuijs

Cancer Res (2020) 80 (4_Supplement): OT1-03-02.

https://doi.org/10.1158/1538-7445.SABCS19-OT1-03-02

Published: 15 February 2020

View article titled, Abstract OT1-03-02: Combining MRI and liquid biopsies for prediction of response to neoadjuvant chemotherapy in early stage breast cancer: The LIMA study

Journal Articles

Abstract OT3-07-01: Efficacy of magnetic resonance-guided high intensity focused ultrasound for the ablation of breast cancer

Josanne Sophia de Maar, Roel Deckers, Lambertus Wilhelmus Bartels, Thijs van Dalen, Joost van Gorp, Paul J van Diest, Arjen J Witkamp, H. H.B. Vaessen, Maria NicoleGerardineJohanna Aleida Braat, Chrit Moonen

Cancer Res (2020) 80 (4_Supplement): OT3-07-01.

https://doi.org/10.1158/1538-7445.SABCS19-OT3-07-01

Published: 15 February 2020

View article titled, Abstract OT3-07-01: Efficacy of magnetic resonance-guided high intensity focused ultrasound for the ablation of breast cancer

Journal Articles

Abstract P5-02-11: Assessment of tumor proliferation by mitotic activity index, phosphohistone H3 and Ki67 in early stage ER+/Her2- breast cancer

Julia E.C. van Steenhoven, Anne Kuijer, A. M. van Leeuwen, Joost M. van Gorp, Paul J. van Diest, Thijs van Dalen

Cancer Res (2020) 80 (4_Supplement): P5-02-11.

https://doi.org/10.1158/1538-7445.SABCS19-P5-02-11

Published: 15 February 2020

View article titled, Abstract P5-02-11: Assessment of tumor proliferation by mitotic activity index, phosphohistone H3 and Ki67 in early stage ER+/Her2- breast cancer

Journal Articles

Abstract P5-02-12: The effect of laboratory-specific feedback reports on grading variation of invasive breast cancer; results of a nationwide study in the Netherlands

Carmen van Dooijeweert, Paul J van Diest, Inge O Baas, Elsken van der Wall, Ivette AG Deckers

Cancer Res (2020) 80 (4_Supplement): P5-02-12.

https://doi.org/10.1158/1538-7445.SABCS19-P5-02-12

Published: 15 February 2020

View article titled, Abstract P5-02-12: The effect of laboratory-specific feedback reports on grading variation of invasive breast cancer; results of a nationwide study in the Netherlands

Journal Articles

Abstract P2-14-19: Patients’ experience with 70-gene signature testing on adjuvant systemic treatment decisions: Results of a prospective cohort study

Julia E.C. van Steenhoven, Bianca den Dekker, Anne Kuijer, Sjoerd G. Elias, Paul J. van Diest, Sabine Siesling, Thijs van Dalen

Cancer Res (2020) 80 (4_Supplement): P2-14-19.

https://doi.org/10.1158/1538-7445.SABCS19-P2-14-19

Published: 15 February 2020

View article titled, Abstract P2-14-19: Patients’ experience with 70-gene signature testing on adjuvant systemic treatment decisions: Results of a prospective cohort study

Journal Articles

Abstract 5874: Targeting DDX3 in medulloblastoma by RK-33

Saritha Tantravedi, Farhad Vesuna, Allison Martin, Michael Lim, Charles G. Eberhart G. Eberhart, Paul J. van Diest, Venu Raman

Cancer Res (2018) 78 (13_Supplement): 5874.

https://doi.org/10.1158/1538-7445.AM2018-5874

Published: 01 July 2018

View article titled, Abstract 5874: Targeting DDX3 in medulloblastoma by RK-33

Journal Articles

Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases

Willemijne A.M.E. Schrijver, Pier Selenica, Ju Youn Lee, Charlotte K.Y. Ng, Kathleen A. Burke, Salvatore Piscuoglio, Samuel H. Berman, Jorge S. Reis-Filho, Britta Weigelt, Paul J. van Diest, Cathy B. Moelans

Cancer Res (2018) 78 (12): 3112–3121.

https://doi.org/10.1158/0008-5472.CAN-17-2310

Published: 14 June 2018

View article titled, Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases

Includes: Supplementary data

Journal Articles

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

Cancer Res (2017) 77 (3): 623–631.

https://doi.org/10.1158/0008-5472.CAN-16-1773

Published: 31 January 2017

View article titled, Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

Includes: Supplementary data

Journal Articles

RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3

Min Xie, Farhad Vesuna, Saritha Tantravedi, Guus M. Bol, Marise R. Heerma van Voss, Katriana Nugent, Reem Malek, Kathleen Gabrielson, Paul J. van Diest, Phuoc T. Tran, Venu Raman

Cancer Res (2016) 76 (21): 6340–6350.

https://doi.org/10.1158/0008-5472.CAN-16-0440

Published: 31 October 2016

View article titled, RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3

Includes: Supplementary data

Journal Articles

Abstract 3164: Molecular determination of the clonal relationship between multiple tumors in BRCA1/2-associated cancer patients has clinical relevance

Willemina R.R. Geurts-Giele, Victorien M.T. van Verschuer, Carolien H.M. van Deurzen, Paul J. van Diest, Rute M. Pedrosa, J. Margriet Collee, Linetta B. Koppert, Caroline Seynaeve, Winand N.M. Dinjens

Cancer Res (2016) 76 (14_Supplement): 3164.

https://doi.org/10.1158/1538-7445.AM2016-3164

Published: 15 July 2016

View article titled, Abstract 3164: Molecular determination of the clonal relationship between multiple tumors in BRCA1/2-associated cancer patients has clinical relevance

Journal Articles

Abstract 3570: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer

Marise R. Heerma van Voss, Farhad Vesuna, Kari Trumpi, Justin Brilliant, Liudmila L. Kodach, Folkert H.M. Morsink, G. Johan A. Offerhaus, Horst Buerger, Elsken van der Wall, Paul J. van Diest, Venu Raman

Cancer Res (2015) 75 (15_Supplement): 3570.

https://doi.org/10.1158/1538-7445.AM2015-3570

Published: 01 August 2015

View article titled, Abstract 3570: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer

Journal Articles

Abstract P6-08-01: Contemporary risk of local, regional and contralateral breast cancer recurrence

Kim C Aalders, Annelotte CM van Bommel, Thijs van Dalen, Gabe S Sonke, Paul J van Diest, Liesbeth J Boersma, Margriet van der Heiden-van der Loo

Cancer Res (2015) 75 (9_Supplement): P6-08-01.

https://doi.org/10.1158/1538-7445.SABCS14-P6-08-01

Published: 01 May 2015

View article titled, Abstract P6-08-01: Contemporary risk of local, regional and contralateral breast cancer recurrence

Journal Articles

Abstract 3005: Vascular endothelial growth factor A - a systematic review and meta-analysis of expression patterns in breast cancer

Arthur Adams, Jeroen Vermeulen, Peter Zuithoff, Elsken Van der Wall, Laetitia Lamberts, Elisabeth de Vries, Johannes de Jong, Gooitzen Van Dam, Paul J. van Diest, Willem P.Th.M. Mali, Sjoerd G. Elias

Cancer Res (2014) 74 (19_Supplement): 3005.

https://doi.org/10.1158/1538-7445.AM2014-3005

Published: 01 October 2014

View article titled, Abstract 3005: Vascular endothelial growth factor A - a systematic review and meta-analysis of expression patterns in breast cancer

Journal Articles

Abstract 3812: Targeting BRCA1-deficient breast cancer by inhibition of the DEAD box RNA helicase DDX3X

Marise R. Heerma van Voss, Farhad Vesuna, Guus M. Bol, Paul J. van Diest, Venu Raman

Cancer Res (2014) 74 (19_Supplement): 3812.

https://doi.org/10.1158/1538-7445.AM2014-3812

Published: 01 October 2014

View article titled, Abstract 3812: Targeting BRCA1-deficient breast cancer by inhibition of the DEAD box RNA helicase DDX3X

Journal Articles

Abstract 4935: Hypoxia targeting fluorescent nanobodies for optical molecular imaging of preinvasive breast cancer

Aram SA van Brussel, Arthur Adams, Sabrina Oliveira, Mohamed E. Khatabbi, Jeroen F. Vermeulen, Elsken Van der Wall, Willem PThM Mali, Patrick W. Derksen, Paul J. Van Diest, Paul MP Van Bergen en Henegouwen

Cancer Res (2014) 74 (19_Supplement): 4935.

https://doi.org/10.1158/1538-7445.AM2014-4935

Published: 01 October 2014

View article titled, Abstract 4935: Hypoxia targeting fluorescent nanobodies for optical molecular imaging of preinvasive breast cancer

Journal Articles

Abstract A52: Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling

Ron C.J. Schackmann, Sjoerd Klarenbeek, Eva J. Vlug, Suzan Stelloo, Miranda van Amersfoort, Milou Tenhagen, Tanya M. Braumuller, Jeroen F. Vermeulen, Petra van der Groep, Ton Peeters, Elsken van der Wall, Paul J. van Diest, Jos Jonkers, Patrick W.B. Derksen

Cancer Res (2013) 73 (19_Supplement): A52.

https://doi.org/10.1158/1538-7445.FBCR13-A52

Published: 15 May 2014

View article titled, Abstract A52: Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling

Journal Articles

Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling

Cancer Res (2013) 73 (15): 4937–4949.

https://doi.org/10.1158/0008-5472.CAN-13-0180

Published: 31 July 2013

View article titled, Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling

Includes: Supplementary data

NARROW

Abstract 3937: An intracellular variant of zona pellucida glycoprotein 3 is expressed in cancer

Abstract P3-12-06: Prognosis of pregnancy-associated breast cancer: Inferior outcome in patients diagnosed during second and third gestational trimesters and lactation

Abstract LB246: E-cadherin loss drives Id2-dependent dampening of cell cycle progression and predicts increased susceptibility to CDK4/6 inhibition in lobular breast cancer

Abstract OT1-03-02: Combining MRI and liquid biopsies for prediction of response to neoadjuvant chemotherapy in early stage breast cancer: The LIMA study

Abstract OT3-07-01: Efficacy of magnetic resonance-guided high intensity focused ultrasound for the ablation of breast cancer

Abstract P5-02-11: Assessment of tumor proliferation by mitotic activity index, phosphohistone H3 and Ki67 in early stage ER+/Her2- breast cancer

Abstract P5-02-12: The effect of laboratory-specific feedback reports on grading variation of invasive breast cancer; results of a nationwide study in the Netherlands

Abstract P2-14-19: Patients’ experience with 70-gene signature testing on adjuvant systemic treatment decisions: Results of a prospective cohort study

Abstract 5874: Targeting DDX3 in medulloblastoma by RK-33

Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases

Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer

RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3

Abstract 3164: Molecular determination of the clonal relationship between multiple tumors in BRCA1/2-associated cancer patients has clinical relevance

Abstract 3570: Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer

Abstract P6-08-01: Contemporary risk of local, regional and contralateral breast cancer recurrence

Abstract 3005: Vascular endothelial growth factor A - a systematic review and meta-analysis of expression patterns in breast cancer

Abstract 3812: Targeting BRCA1-deficient breast cancer by inhibition of the DEAD box RNA helicase DDX3X

Abstract 4935: Hypoxia targeting fluorescent nanobodies for optical molecular imaging of preinvasive breast cancer

Abstract A52: Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling

Loss of p120-Catenin Induces Metastatic Progression of Breast Cancer by Inducing Anoikis Resistance and Augmenting Growth Factor Receptor Signaling

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only